Diffuse lung disease: product of genetic susceptibility and environmental encounters
- 1 January 1997
- Vol. 52 (1) , 92-94
- https://doi.org/10.1136/thx.52.1.92
Abstract
Diffuse (interstitial) lung disease comprises a wide variety of conditions, individually relatively uncommon but collectively being found in approximately 50 per 100,000 population. Some of these diseases are of known aetiology but others are not. It has been suggested that the environment is a major contributory factor in this group of diseases. However, since not all individuals exposed to a common environment develop interstitial diseases, it can be hypothesised that there is a genetic predisposition to their development. These diseases cause major morbidity and mortality due to lung injury and fibrosis. It follows that, if individuals who are genetically predisposed to develop diseases characterised by lung injury and fibrosis can be identified, then management strategies can be designed which will attempt to identify and treat early disease and, in the longer term, to develop targeted genetic interventional approaches to treatment.Keywords
This publication has 6 references indexed in Scilit:
- THE GENETICIST'S APPROACH TO COMPLEX DISEASEAnnual Review of Medicine, 1996
- "The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries.American Journal of Respiratory and Critical Care Medicine, 1995
- Genetics of sclerodermaClinics in Dermatology, 1994
- Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA studyClinical and Experimental Immunology, 1994
- HLA-DPB1 Glutamate 69: a Genetic Marker of Beryllium DiseaseScience, 1993
- Restricted Vα2.3 gene usage by CD4+ T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA‐DR3European Journal of Immunology, 1992